Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Patients who discontinued cancer immunotherapy because of immune-related adverse events (irAEs) often had durable benefits ...

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

PRRDetect is a new algorithm that identifies tumors with faulty DNA repair, helping doctors tailor cancer treatments more ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

John Mellencamp's daughter remembers the call she got from him to say her sister Teddi's cancer had returned. 'Drop ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and ...